Development of the RapidMist(TM) drug delivery system for the development of diabetes, cardiovascular diseases and breakthrough cancer pain

AbstractWearable devices have found numerous applications in healthcare ranging from physiological diseases, such as cardiovascular diseases, hypertension and muscle disorders to neurocognitive disorders, such as Parkinson’s disease, Alzheimer’s disease and other psychological diseases. Different types of wearables are used for this purpose, for example, skin-based wearables including tattoo-based wearables, textile-based wearables, and biofluidic-based wearables. Recently, wearables have also shown encouraging improvements as a drug delivery system; therefore, enhancing its utility towards personalized healthcare. These wearables contain inherent challenges, which need to be addressed before their commercialization as a fully personalized healthcare system. This paper reviews different types of wearable devices currently being used in the healthcare field. It also highlights their efficacy in monitoring different diseases and applications of healthcare wearable devices (HWDs) for diagnostic and treatment purposes. Additionally, current challenges and limitations of these wearables in the field of healthcare along with their future perspectives are also reviewed.

Download Full-text

Intrathecal Drug Delivery System Trialing for Cancer Pain Management

Essentials of Interventional Cancer Pain Management ◽

10.1007/978-3-319-99684-4_30 ◽

2018 ◽

pp. 273-276

Author(s):

Namrata Khimani ◽

Sanjeet Narang

Keyword(s):

Drug Delivery ◽

Pain Management ◽

Cancer Pain ◽

Drug Delivery System ◽

Delivery System ◽

Cancer Pain Management ◽

Intrathecal Drug Delivery

Download Full-text

Intrathecal Drug Delivery System (IDDS) for Cancer Pain Management

American Journal of Hospice and Palliative Medicine® ◽

10.1177/1049909111426134 ◽

2011 ◽

Vol 29 (5) ◽

pp. 388-398 ◽

Cited By ~ 17

Author(s):

Surjya Prasad Upadhyay ◽

Piyush N. Mallick

Keyword(s):

Drug Delivery ◽

Pain Management ◽

Cancer Pain ◽

Drug Delivery System ◽

Delivery System ◽

Cancer Pain Management ◽

Patients With Cancer ◽

Intrathecal Drug Delivery ◽

Number Of Patients ◽

Interventional Pain Management

Cancer pain remains undertreated and a significant number of patients with cancer pain die from severe untreated pain. With increasing survival rate in cancer, the prevalence of cancer pain is also increasing in number. Though majority of patients with cancer pain can be effectively treated with conventional medical management, still a significant portion of patients required some form of interventional pain management techniques. Among the interventional techniques, intrathecal drug delivery is increasingly used in cancer pain management. Our objective of this article is to review literatures and clinical studies on intrathecal drug delivery system (IDDS) in cancer pain management and to provide updates on its use, precautions, contraindications, side effects and its management, socioeconomic consideration, and management of IDDS in difficult or uncommon situations.

Download Full-text